Fierce Pharma

DECEMBER 3, 2023

As AbbVie, Johnson & Johnson, AstraZeneca and BeiGene are battling it out in the same BTK inhibitor market, Eli Lilly is trailblazing a new path for the blood cancer drug class. | As AbbVie and Johnson & Johnson, AstraZeneca and BeiGene are battling it out in the same BTK inhibitor market, Eli Lilly is trailblazing a new path for the blood cancer drug class with an accelerated approval in post BTK/BCL-2 chronic lymphocytic leukemia.

FDA 272

FDA Marketing 272

MedCity News

DECEMBER 3, 2023

Healthcare has traditionally been built around the convenience of the provider and not the patient. Worse, it tends to treat all patients the same regardless of the condition they are trying to manage. If we want to improve medication compliance, we have to make access, support, and most importantly financial assistance a priority.

Medical 118

Medical Healthcare Healthcare Management 118

Copyright Clearance Center

DECEMBER 3, 2023

Books remain a dominant format, though reading and discussing stories, as well as the IP generated from books, have become integrated in consumers’ experiences and on publishers’ spreadsheets.

92

92

MedCity News

DECEMBER 3, 2023

The top three areas of concern for employers in 2024 include rising healthcare costs, mental health challenges and cancer care, according to a recent report from Business Group on Health.

Healthcare 112

Healthcare Healthcare 112

Advertisement

Distribution

Veeva

DECEMBER 3, 2023

Throughout the history of life sciences companies, events have played a crucial role as a promotional avenue for introducing new products and offering scientific education. Customers find value in attending life sciences events for several reasons. Firstly, these events serve as a platform for increasing awareness and engagement, allowing attendees to stay informed about the latest developments and advancements in the field.

CRM 52

CRM Management Education Marketing 52

MedCity News

DECEMBER 3, 2023

The next era for mRNA-based therapeutics and vaccines is here, and it’s time to move from an R&D mindset to a focus on long-term success with mRNA and bringing these innovative therapeutics to patients at scale.

Patients 111

Patients Biopharma 111

MedCity News

DECEMBER 3, 2023

With at-home STI testing kits, people can get tested in the comfort and privacy of their own homes. These test kits are available at most pharmacies and are easy to use.

104

104

Copyright Clearance Center

DECEMBER 3, 2023

The post Copyright Clearance Center Wins 2023 European Best of Show Award for Scientific Article Exploration Tool appeared first on Copyright Clearance Center.

40

40

MedCity News

DECEMBER 3, 2023

Bright Uro raised $23 million in Series A funds to help achieve FDA clearance for its urodynamics system and launch the product in the U.S. Should it be cleared, the system will become the first product on the market able perform urodynamic monitoring wirelessly and without a catheter, the company’s CEO said.

Patients 91

Patients FDA Marketing 91